title,datetime,link
NASH: The Second Wave,2020-02-20 00:00:00,https://news.google.com/./articles/CBMiOWh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQzMjU4OTktbmFzaC1zZWNvbmQtd2F2ZdIBAA?hl=en-US&gl=US&ceid=US%3Aen
"Benzinga's Top Upgrades, Downgrades For February 10, 2020 - Adverum Biotechnologies (NASDAQ:ADVM), Akero",2020-02-10 00:00:00,https://news.google.com/./articles/CBMiJmh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9ub2RlLzE1MjkwMDY50gEtaHR0cHM6Ly93d3cuYmVuemluZ2EuY29tL2FtcC9jb250ZW50LzE1MjkwMDY5?hl=en-US&gl=US&ceid=US%3Aen
Will FDA Approve First NASH Drug In 2020?,2020-04-09 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvd2lsbC1mZGEtYXBwcm92ZS1maXJzdC1uYXNoLWRydWctaW4tMjAyMC0yMDIwLTA0LTA50gEA?hl=en-US&gl=US&ceid=US%3Aen
Is Standex International Corp. (SXI) A Good Stock To Buy?,2020-06-25 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9zdGFuZGV4LWludGVybmF0aW9uYWwtY29ycC1zeGktZ29vZC0yMDUwMjE4NjQuaHRtbNIBWWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL3N0YW5kZXgtaW50ZXJuYXRpb25hbC1jb3JwLXN4aS1nb29kLTIwNTAyMTg2NC5odG1s?hl=en-US&gl=US&ceid=US%3Aen
Akero Therapeutics Announces Closing of Upsized Public Offering ...,2020-07-10 00:00:00,https://news.google.com/./articles/CBMizgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FrZXJvLXRoZXJhcGV1dGljcy1hbm5vdW5jZXMtY2xvc2luZy1vZi11cHNpemVkLXB1YmxpYy1vZmZlcmluZy1vZi1jb21tb24tc3RvY2stYW5kLWZ1bGwtZXhlcmNpc2Utb2YtdW5kZXJ3cml0ZXJzLW9wdGlvbi10by1wdXJjaGFzZS1hZGRpdGlvbmFsLXNoYXJlcy0zMDEwOTE2NjYuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Nine Square Therapeutics Launches With $50M in Series A,2020-07-05 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmZpbnNtZXMuY29tLzIwMjAvMDcvbmluZS1zcXVhcmUtdGhlcmFwZXV0aWNzLWxhdW5jaGVzLXdpdGgtNTBtLWluLXNlcmllcy1hLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
"In race to defeat fatty liver disease, biotech Sagimet lines up next ...",2020-07-10 00:00:00,https://news.google.com/./articles/CBMia2h0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDIwLzA3LzEwL25hc2gtZmF0dHktbGl2ZXItZGlzZWFzZS1zYWdpbWV0LWdpbGVhZC1ha2Vyby5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen
89bio: Near And Long-Term Investment Cases Excite As Company ...,2020-10-14 00:00:00,https://news.google.com/./articles/CBMiemh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQzNzkxMTktODliaW8tbmVhci1hbmQtbG9uZy10ZXJtLWludmVzdG1lbnQtY2FzZXMtZXhjaXRlLWNvbXBhbnktdGFyZ2V0cy1uYXNoLW9wcG9ydHVuaXR50gEA?hl=en-US&gl=US&ceid=US%3Aen
Analysis Of The Non-alcoholic Steatohepatitis (NASH) Drug Pipeline ...,2020-12-07 00:00:00,https://news.google.com/./articles/CBMikAFodHRwczovL3d3dy5waGFybWFjZXV0aWNhbG9ubGluZS5jb20vZG9jL2FuYWx5c2lzLW9mLXRoZS1ub24tYWxjb2hvbGljLXN0ZWF0b2hlcGF0aXRpcy1uYXNoLWRydWctcGlwZWxpbmUtbWFya2V0LXRoZS1zZWNvbmQtd2F2ZS1jYW5kaWRhdGVzLTAwMDHSAQA?hl=en-US&gl=US&ceid=US%3Aen
Vera Therapeutics Launches with $80 Million Series C Financing to ...,2021-01-19 00:00:00,https://news.google.com/./articles/CBMiqwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3ZlcmEtdGhlcmFwZXV0aWNzLWxhdW5jaGVzLXdpdGgtODAtbWlsbGlvbi1zZXJpZXMtYy1maW5hbmNpbmctdG8tZGV2ZWxvcC1waGFzZS0yYi1ub3ZlbC1iaW9sb2dpYy1mb3Ita2lkbmV5LWRpc2Vhc2UtMzAxMjA5NjA3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
"Nonalcoholic Steatohepatitis Drug Pipeline Analysis Review, 2020",2021-01-13 00:00:00,https://news.google.com/./articles/CBMiigFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAyMS8wMS8xNC8yMTU4MzIwLzAvZW4vTm9uYWxjb2hvbGljLVN0ZWF0b2hlcGF0aXRpcy1EcnVnLVBpcGVsaW5lLUFuYWx5c2lzLVJldmlldy0yMDIwLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
Akero Therapeutics: A NASH Pureplay With Differentiated Mid Stage ...,2021-05-18 00:00:00,https://news.google.com/./articles/CBMibmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ0MjcyNjMtYWtlcm8tdGhlcmFwZXV0aWNzLWEtbmFzaC1wdXJlcGxheS13aXRoLWRpZmZlcmVudGlhdGVkLW1pZC1zdGFnZS1kYXRh0gEA?hl=en-US&gl=US&ceid=US%3Aen
Bristol Myers' (BMY) Zeposia Gets FDA Nod for Ulcerative Colitis,2021-05-28 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvYnJpc3RvbC1teWVycy1ibXktemVwb3NpYS1nZXRzLWZkYS1ub2QtZm9yLXVsY2VyYXRpdmUtY29saXRpcy0yMDIxLTA1LTI40gEA?hl=en-US&gl=US&ceid=US%3Aen
NGM sinks after NASH drug hopeful fails mid-stage clinical trial ...,2021-05-24 00:00:00,https://news.google.com/./articles/CBMibWh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDIxLzA1LzI0L25hc2gtZmF0dHktbGl2ZXItbmdtLWdpbGVhZC1naWxkLWFrcm8tdGVybi1wbHJ4Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
venBio Writes New Chapter with $550M Fourth Fund,2021-06-14 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2dlbi1lZGdlL3ZlbmJpby13cml0ZXMtbmV3LWNoYXB0ZXItd2l0aC01NTBtLWZvdXJ0aC1mdW5kL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Ambrx Biopharma Pursues $126 Million U.S. IPO (Pending:AMAM),2021-06-15 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ0MzQ5MzgtYW1icngtYmlvcGhhcm1hLXB1cnN1ZXMtMTI2LW1pbGxpb24tdXMtaXBv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Study Published in Nature Medicine Shows Investigational NASH ...,2021-07-08 00:00:00,https://news.google.com/./articles/CBMi4gFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAyMS8wNy8wOC8yMjYwMTA2LzAvZW4vU3R1ZHktUHVibGlzaGVkLWluLU5hdHVyZS1NZWRpY2luZS1TaG93cy1JbnZlc3RpZ2F0aW9uYWwtTkFTSC1EcnVnLVJlZHVjZWQtTGl2ZXItRmF0LXRvLU5vcm1hbC1MZXZlbHMtYW5kLVJldmVyc2VkLUZpYnJvc2lzLUFmdGVyLTE2LVdlZWtzLW9mLVRyZWF0bWVudC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen
89bio Stock: Undervalued Contender In Race For First NASH Drug ...,2021-07-20 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ0NDAwNDYtODliaW8tdW5kZXJ2YWx1ZWQtY29udGVuZGVyLWluLXJhY2UtZm9yLWZpcnN0LW5hc2gtZHJ1Zy1hcHByb3ZhbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Prothena sells ATTR program to Novo in deal worth up to $1.2B,2021-07-12 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3dvcmxkLmNvbS9hcnRpY2xlcy81MDkyMjktcHJvdGhlbmEtc2VsbHMtYXR0ci1wcm9ncmFtLXRvLW5vdm8taW4tZGVhbC13b3J0aC11cC10by0xMmLSAQA?hl=en-US&gl=US&ceid=US%3Aen
Fatty liver still unseen in the metabolic 'constellation of risk',2021-08-23 00:00:00,https://news.google.com/./articles/CBMidWh0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9nYXN0cm9lbnRlcm9sb2d5LzIwMjEwODE3L2ZhdHR5LWxpdmVyLXN0aWxsLXVuc2Vlbi1pbi10aGUtbWV0YWJvbGljLWNvbnN0ZWxsYXRpb24tb2Ytcmlza9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Form N-PX VANGUARD SCOTTSDALE FUND For: Jun 30,2021-08-27 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LnN0cmVldGluc2lkZXIuY29tL1NFQytGaWxpbmdzL0Zvcm0rTi1QWCtWQU5HVUFSRCtTQ09UVFNEQUxFK0ZVTkQrRm9yJTNBK0p1biszMC8xODg3NDA1Ny5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen
Ventyx Biosciences Announces Key Appointments and Closing of ...,2021-09-20 00:00:00,https://news.google.com/./articles/CBMixgFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMS8wOS8yMC8yMjk5NTI0LzAvZW4vVmVudHl4LUJpb3NjaWVuY2VzLUFubm91bmNlcy1LZXktQXBwb2ludG1lbnRzLWFuZC1DbG9zaW5nLW9mLTUxLTAtTWlsbGlvbi1TZXJpZXMtQi1Db252ZXJ0aWJsZS1QcmVmZXJyZWQtU3RvY2stRmluYW5jaW5nLVJvdW5kLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
"Pioneer Municipal High Income Fund, Inc. (MHI) Ex-Dividend Date ...",2021-09-14 00:00:00,https://news.google.com/./articles/CBMid2h0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvcGlvbmVlci1tdW5pY2lwYWwtaGlnaC1pbmNvbWUtZnVuZC1pbmMuLW1oaS1leC1kaXZpZGVuZC1kYXRlLXNjaGVkdWxlZC1mb3Itc2VwdGVtYmVyLTE10gEA?hl=en-US&gl=US&ceid=US%3Aen
This Could Be the Most Expensive Home Insurance Mistake,2021-09-12 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvdGhpcy1jb3VsZC1iZS10aGUtbW9zdC1leHBlbnNpdmUtaG9tZS1pbnN1cmFuY2UtbWlzdGFrZS0yMDIxLTA5LTEy0gEA?hl=en-US&gl=US&ceid=US%3Aen
Akero Therapeutics Receives FDA Fast Track Designation for ...,2021-10-19 00:00:00,https://news.google.com/./articles/CBMisAFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAyMS8xMC8xOS8yMzE2OTAxLzAvZW4vQWtlcm8tVGhlcmFwZXV0aWNzLVJlY2VpdmVzLUZEQS1GYXN0LVRyYWNrLURlc2lnbmF0aW9uLWZvci1FZnJ1eGlmZXJtaW4tRUZYLWZvci10aGUtVHJlYXRtZW50LW9mLU5BU0guaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Efruxifermin Fast Tracked for Nonalcoholic Steatohepatitis - MPR,2021-10-20 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmVtcHIuY29tL2hvbWUvbmV3cy9kcnVncy1pbi10aGUtcGlwZWxpbmUvZWZydXhpZmVybWluLWZhc3QtdHJhY2tlZC1mb3Itbm9uYWxjb2hvbGljLXN0ZWF0b2hlcGF0aXRpcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Akero Presents New Analysis of Phase 2a BALANCED Study Data ...,2021-11-12 00:00:00,https://news.google.com/./articles/CBMi_wFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAyMS8xMS8xMi8yMzMzNDExLzAvZW4vQWtlcm8tUHJlc2VudHMtTmV3LUFuYWx5c2lzLW9mLVBoYXNlLTJhLUJBTEFOQ0VELVN0dWR5LURhdGEtU2hvd2luZy1BZGRpdGlvbmFsLVF1YWxpdGF0aXZlLUV2aWRlbmNlLW9mLUhpc3RvbG9naWNhbC1JbXByb3ZlbWVudC1pbi1FRlgtdHJlYXRlZC1OQVNILVBhdGllbnRzLWFmdGVyLTE2LVdlZWtzLW9mLVRyZWF0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
Intercept Plans To Refile OCA For NASH At US FDA With ...,2021-11-17 00:00:00,https://news.google.com/./articles/CBMijgFodHRwczovL3BpbmsucGhhcm1haW50ZWxsaWdlbmNlLmluZm9ybWEuY29tL1BTMTQ1Mjc0L0ludGVyY2VwdC1QbGFucy1Uby1SZWZpbGUtT0NBLUZvci1OQVNILUF0LVVTLUZEQS1XaXRoLUNvbnNlbnN1cy1SZWFkcy1PZi1QYXRpZW50LUJpb3BzaWVz0gEA?hl=en-US&gl=US&ceid=US%3Aen
EUR/USD Daily Forecast â€“ Test Of Support At 1.1300,2021-12-03 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvZXVyLXVzZC1kYWlseS1mb3JlY2FzdC10ZXN0LW9mLXN1cHBvcnQtYXQtMS4xMzAw0gEA?hl=en-US&gl=US&ceid=US%3Aen
"JPM22, Day 2: Sage's double-duty anxiety drug; Dexcom shows off ...",2022-01-11 00:00:00,https://news.google.com/./articles/CBMiMWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvanBtMjItZGF5LTLSAQA?hl=en-US&gl=US&ceid=US%3Aen
"Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors",2022-01-06 00:00:00,https://news.google.com/./articles/CBMijQFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAyMi8wMS8wNi8yMzYyMzIzLzAvZW4vWGlsaW8tVGhlcmFwZXV0aWNzLUFwcG9pbnRzLVl1YW4tWHUtUGgtRC10by1pdHMtQm9hcmQtb2YtRGlyZWN0b3JzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
NGM Biopharmaceuticals Inc. (NASDAQ: NGM) Receives Fast Track ...,2022-02-22 00:00:00,https://news.google.com/./articles/CBMiqwFodHRwczovL2Jpb3BoYXJtYWpvdXJuYWwuY29tLzIwMjIvMDIvMjIvbmdtLWJpb3BoYXJtYWNldXRpY2Fscy1pbmMtbmFzZGFxLW5nbS1yZWNlaXZlcy1mYXN0LXRyYWNrLWRlc2lnbmF0aW9uLWZvci1tZ202MjEtZm9yLWdlb2dyYXBoaWMtYXRyb3BoeS1zZWNvbmRhcnktdG8tYW1kLXRyZWF0bWVudC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
We're Not Very Worried About Akero Therapeutics' (NASDAQ:AKRO) Cash Burn Rate,2022-05-04 00:00:00,https://news.google.com/./articles/CBMimgFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1ha3JvL2FrZXJvLXRoZXJhcGV1dGljcy9uZXdzL3dlcmUtbm90LXZlcnktd29ycmllZC1hYm91dC1ha2Vyby10aGVyYXBldXRpY3MtbmFzZGFxYWtyby1jYS0x0gGeAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvdXMvcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbmFzZGFxLWFrcm8vYWtlcm8tdGhlcmFwZXV0aWNzL25ld3Mvd2VyZS1ub3QtdmVyeS13b3JyaWVkLWFib3V0LWFrZXJvLXRoZXJhcGV1dGljcy1uYXNkYXFha3JvLWNhLTEvYW1w?hl=en-US&gl=US&ceid=US%3Aen
20 Things You Didn't Know About SonarSource,2022-05-04 00:00:00,https://news.google.com/./articles/CBMiIWh0dHBzOi8vbW9uZXlpbmMuY29tL3NvbmFyc291cmNlL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer makes $25M equity investment in Akero (NASDAQ:AKRO),2022-06-16 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9uZXdzLzM4NDkxNjAtcGZpemVyLW1ha2VzLTI1bS1lcXVpdHktaW52ZXN0bWVudC1pbi1ha2Vyb9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer dumps another potential NASH therapy,2022-07-28 00:00:00,https://news.google.com/./articles/CBMibWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvbmFzaC1jdXJzZS1zdHJpa2VzLWFnYWluLXBmaXplci1kdW1wcy1lYXJseS1zdGFnZS1hc3NldC1saXZlci1jb25kaXRpb27SAQA?hl=en-US&gl=US&ceid=US%3Aen
"After initial failure, Intercept Pharma feels new data can get NASH ...",2022-07-07 00:00:00,https://news.google.com/./articles/CBMicWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMjIvMDcvYWZ0ZXItaW5pdGlhbC1mYWlsdXJlLWludGVyY2VwdC1waGFybWEtZmVlbHMtbmV3LWRhdGEtY2FuLWdldC1uYXNoLWRydWctYXBwcm92YWwv0gEA?hl=en-US&gl=US&ceid=US%3Aen
20 Things You Didn't Know about Notch,2022-07-10 00:00:00,https://news.google.com/./articles/CBMiG2h0dHBzOi8vbW9uZXlpbmMuY29tL25vdGNoL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
89bio: NASH Data Next Year May Change Things For The Better ...,nan,https://news.google.com/./articles/CBMiV2h0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1MzYzMTktODliaW8tbmFzaC1kYXRhLW5leHQteWVhci1jaGFuZ2UtdGhpbmdzLWJldHRlctIBAA?hl=en-US&gl=US&ceid=US%3Aen
Legend Biotech Appoints Three New Directors and Elects New ...,2022-08-04 00:00:00,https://news.google.com/./articles/CBMiiQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMDgwNDAwNTc4Ny9lbi9MZWdlbmQtQmlvdGVjaC1BcHBvaW50cy1UaHJlZS1OZXctRGlyZWN0b3JzLWFuZC1FbGVjdHMtTmV3LUNoYWlybWFuLW9mLXRoZS1Cb2FyZNIBAA?hl=en-US&gl=US&ceid=US%3Aen
FibroGen completes patient enrollment for Roxadustat to treat ...,nan,https://news.google.com/./articles/CBMidmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9uZXdzLzM4NzcwNzgtZmlicm9nZW4tY29tcGxldGVzLXBhdGllbnQtZW5yb2xsbWVudC1mb3Itcm94YWR1c3RhdC10by10cmVhdC1hbmVtaWEtaW4tcGF0aWVudHPSAQA?hl=en-US&gl=US&ceid=US%3Aen
Akero Therapeutics Announces Pricing of Upsized Public Offering of ...,nan,https://news.google.com/./articles/CBMilwFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMi8wOS8xNS8yNTE2NDYxLzAvZW4vQWtlcm8tVGhlcmFwZXV0aWNzLUFubm91bmNlcy1QcmljaW5nLW9mLVVwc2l6ZWQtUHVibGljLU9mZmVyaW5nLW9mLUNvbW1vbi1TdG9jay5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Akero's drug meets main goal in NASH trial, shares surge 120%",nan,https://news.google.com/./articles/CBMiiwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9ha2Vyby10aGVyYXBldXRpY3MtbGVhZC1kcnVnLW1lZXRzLW1haW4tZ29hbC1uYXNoLXRyaWFsLXNoYXJlcy1qdW1wLTIwMjItMDktMTMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Akero Therapeutics: Outstanding Data In NASH (NASDAQ:AKRO),nan,https://news.google.com/./articles/CBMiVGh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1NDEyOTgtYWtlcm8tdGhlcmFwZXV0aWNzLW91dHN0YW5kaW5nLWRhdGEtaW4tbmFzaNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Akero Therapeutics to Present Results from Phase 2b HARMONY ...,nan,https://news.google.com/./articles/CBMiywFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAyMi8wOS8wOC8yNTEyOTM1LzAvZW4vQWtlcm8tVGhlcmFwZXV0aWNzLXRvLVByZXNlbnQtUmVzdWx0cy1mcm9tLVBoYXNlLTJiLUhBUk1PTlktVHJpYWwtSW52ZXN0aWdhdGluZy1FZnJ1eGlmZXJtaW4taW4tUGF0aWVudHMtd2l0aC1QcmUtQ2lycmhvdGljLU5BU0guaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Liver Fibrosis Market to Surge at a CAGR of 15.9% by 2032 ...,nan,https://news.google.com/./articles/CBMifmh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvbGl2ZXItZmlicm9zaXMtbWFya2V0LXRvLXN1cmdlLWF0LWEtY2Fnci1vZi0xNS05LWJ5LTIwMzItLWRlbHZlaW5zaWdodC0zMDE2MTc2NjUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday - Apple (NASDAQ:AA,nan,https://news.google.com/./articles/CBMigQFodHRwczovL3d3dy5iZW56aW5nYS5jb20vbmV3cy8yMi8wOS8yODg2MDIxOC93aHktY29tZXJhLWxpZmUtc2NpZW5jZXMtc2hhcmVzLWp1bXBlZC0xMDEtaGVyZS1hcmUtNzQtYmlnZ2VzdC1tb3ZlcnMtZnJvbS15ZXN0ZXJkYXnSAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMjg4NjAyMTg?hl=en-US&gl=US&ceid=US%3Aen
StockWatch: BioNTech Sees No Bounce from Promising Cancer ...,nan,https://news.google.com/./articles/CBMiiwFodHRwczovL3d3dy5nZW5lbmduZXdzLmNvbS90b3BpY3MvZHJ1Zy1kaXNjb3ZlcnkvdmFjY2luZS1kZXZlbG9wbWVudC9zdG9ja3dhdGNoLWJpb250ZWNoLXNlZXMtbm8tYm91bmNlLWZyb20tcHJvbWlzaW5nLWNhbmNlci12YWNjaW5lLWRhdGEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"NTLA Stock Hammered, Dragging Other CRISPR Stocks, On New ...",nan,https://news.google.com/./articles/CBMidmh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2NyaXNwci1zdG9jay13aWxsLWludGVsbGlhLWxhdGVzdC1nZW5lLWVkaXRpbmctZWZmb3J0LWJ1b3ktdGhlLW1hcmtldC1hZ2Fpbi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Finance Watch: Third Harmonic Launches The Largest IPO In Months,nan,https://news.google.com/./articles/CBMidWh0dHBzOi8vc2NyaXAucGhhcm1haW50ZWxsaWdlbmNlLmluZm9ybWEuY29tL1NDMTQ3MDY0L0ZpbmFuY2UtV2F0Y2gtVGhpcmQtSGFybW9uaWMtTGF1bmNoZXMtVGhlLUxhcmdlc3QtSVBPLUluLU1vbnRoc9IBAA?hl=en-US&gl=US&ceid=US%3Aen
ChargePoint Holdings Inc (NYSE:CHPT) unusual options activity ...,nan,https://news.google.com/./articles/CBMigAFodHRwczovL2Jpb3BoYXJtYWpvdXJuYWwuY29tLzIwMjIvMDkvMTMvY2hhcmdlcG9pbnQtaG9sZGluZ3MtaW5jLW55c2VjaHB0LXVudXN1YWwtb3B0aW9ucy1hY3Rpdml0eS1pbmRpY2F0ZXMtaW5jcmVhc2VkLWludGVyZXN0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Xilio Therapeutics Appoints Tomas J. Heyman to Board of Directors,nan,https://news.google.com/./articles/CBMiiwFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAyMi8wOS8xNS8yNTE3MjczLzAvZW4vWGlsaW8tVGhlcmFwZXV0aWNzLUFwcG9pbnRzLVRvbWFzLUotSGV5bWFuLXRvLUJvYXJkLW9mLURpcmVjdG9ycy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen
U.S. shares lower at close of trade; Dow Jones Industrial Average ...,nan,https://news.google.com/./articles/CBMibWh0dHBzOi8vaW4uaW52ZXN0aW5nLmNvbS9uZXdzL3VzLXNoYXJlcy1sb3dlci1hdC1jbG9zZS1vZi10cmFkZS1kb3ctam9uZXMtaW5kdXN0cmlhbC1hdmVyYWdlLWRvd24tMzk0LTMzNDI1MDnSAQA?hl=en-US&gl=US&ceid=US%3Aen
What Is Going on With NeuroBo (NRBO) Stock Today?,nan,https://news.google.com/./articles/CBMiUWh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMi8wOS93aGF0LWlzLWdvaW5nLW9uLXdpdGgtbmV1cm9iby1ucmJvLXN0b2NrLXRvZGF5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Cardiff Oncology: 41% Loss In One Day For A Best-In-Class ...,nan,https://news.google.com/./articles/CBMiggFodHRwczovL3NlZWtpbmdhbHBoYS5jb20vYXJ0aWNsZS80NTQwOTEwLWNhcmRpZmYtb25jb2xvZ3ktNDEtcGVyY2VudC1sb3NzLWluLW9uZS1kYXktZm9yLWJlc3QtaW4tY2xhc3MtY29sb3JlY3RhbC1jYW5jZXItdHJlYXRtZW500gEA?hl=en-US&gl=US&ceid=US%3Aen
Akero Therapeutics - Biotechnology,nan,https://news.google.com/./articles/CBMiSWh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1NDYwNDEtYWtlcm8tdGhlcmFwZXV0aWNzLWJpb3RlY2hub2xvZ3nSAQA?hl=en-US&gl=US&ceid=US%3Aen
Akero Stock: Putting Together The Pieces They Let Us See,nan,https://news.google.com/./articles/CBMiWmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1NDkwODgtYWtlcm8tcHV0dGluZy10b2dldGhlci10aGUtcGllY2VzLXRoZXktbGV0LXVzLXNlZdIBAA?hl=en-US&gl=US&ceid=US%3Aen
89bio Still Has A Chance As NASH Race Heats Up (NASDAQ:ETNB),nan,https://news.google.com/./articles/CBMiUmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1NDUxNTAtODliaW8tc3RpbGwtaGFzLWNoYW5jZS1uYXNoLXJhY2UtaGVhdHMtdXDSAQA?hl=en-US&gl=US&ceid=US%3Aen
These Are The Five Best And Worst Performing Small-cap Stocks In ...,nan,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LnZhbHVld2Fsay5jb20vYmVzdC1hbmQtd29yc3QtcGVyZm9ybWluZy1zbWFsbC1jYXAtc3RvY2tzLWluLXNlcHRlbWJlci0yMDIyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Biotech Stocks Well-Positioned For Fourth Quarter,nan,https://news.google.com/./articles/CBMiWmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1NDU2NDktYmlvdGVjaC1zdG9ja3Mtd2VsbC1wb3NpdGlvbmVkLWZvci1mb3VydGgtcXVhcnRlctIBAA?hl=en-US&gl=US&ceid=US%3Aen
These Were The Five Best And Worst Performing Healthcare Stocks ...,nan,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LnZhbHVld2Fsay5jb20vYmVzdC13b3JzdC1wZXJmb3JtaW5nLWhlYWx0aGNhcmUtc3RvY2tzLWluLXNlcHRlbWJlci0yMDIyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Gilead (GILD) Inks Deal for Gene Platform in Blood Cancers,nan,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzE5OTU4MjMvZ2lsZWFkLWdpbGQtaW5rcy1kZWFsLWZvci1nZW5lLXBsYXRmb3JtLWluLWJsb29kLWNhbmNlcnPSAWVodHRwczovL3d3dy56YWNrcy5jb20vYW1wL3N0b2NrL25ld3MvMTk5NTgyMy9naWxlYWQtZ2lsZC1pbmtzLWRlYWwtZm9yLWdlbmUtcGxhdGZvcm0taW4tYmxvb2QtY2FuY2Vycw?hl=en-US&gl=US&ceid=US%3Aen
Axsome: Ramifications Of Recent Biotech Deals (NASDAQ:AXSM),nan,https://news.google.com/./articles/CBMiVWh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1NTA4MjQtYXhzb21lLXJhbWlmaWNhdGlvbnMtb2YtcmVjZW50LWJpb3RlY2gtZGVhbHPSAQA?hl=en-US&gl=US&ceid=US%3Aen
CytoDyn Stock: Repositioning And Refocusing With New ...,nan,https://news.google.com/./articles/CBMiYWh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1NDY5MzYtY3l0b2R5bi1yZXBvc2l0aW9uaW5nLWFuZC1yZWZvY3VzaW5nLXdpdGgtbmV3LWxlYWRlcnNoaXDSAQA?hl=en-US&gl=US&ceid=US%3Aen
Akero Therapeutics Reports Third Quarter 2022 Financial Results ...,nan,https://news.google.com/./articles/CBMipwFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAyMi8xMS8wNC8yNTQ4NjI0LzAvZW4vQWtlcm8tVGhlcmFwZXV0aWNzLVJlcG9ydHMtVGhpcmQtUXVhcnRlci0yMDIyLUZpbmFuY2lhbC1SZXN1bHRzLWFuZC1Qcm92aWRlcy1CdXNpbmVzcy1VcGRhdGUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Akero Therapeutics: What Is Making The Stock Tick (NASDAQ:AKRO),nan,https://news.google.com/./articles/CBMiWWh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1NjAxNTQtYWtlcm8tdGhlcmFwZXV0aWNzLXdoYXQtaXMtbWFraW5nLXRoZS1zdG9jay10aWNr0gEA?hl=en-US&gl=US&ceid=US%3Aen
Novo Nordisk's (NVO) Q3 Earnings & Revenues Beat Estimates,nan,https://news.google.com/./articles/CBMiVWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvbm92by1ub3JkaXNrcy1udm8tcTMtZWFybmluZ3MtcmV2ZW51ZXMtYmVhdC1lc3RpbWF0ZXPSAQA?hl=en-US&gl=US&ceid=US%3Aen
"Imminent Madrigal, Viking Trial Readouts Will Shape NASH R&D ...",nan,https://news.google.com/./articles/CBMifWh0dHBzOi8vc2NyaXAucGhhcm1haW50ZWxsaWdlbmNlLmluZm9ybWEuY29tL1NDMTQ3MzQwL0ltbWluZW50LU1hZHJpZ2FsLVZpa2luZy1UcmlhbC1SZWFkb3V0cy1XaWxsLVNoYXBlLU5BU0gtUkQtRXhwZWN0YXRpb25z0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Deciphera's (DCPH) Q3 Loss Narrows, Qinlock Drives Revenues",nan,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvZGVjaXBoZXJhcy1kY3BoLXEzLWxvc3MtbmFycm93cy1xaW5sb2NrLWRyaXZlcy1yZXZlbnVlc9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Efruxifermin induces NASH resolution, improves fibrosis by at least 1 ...",nan,https://news.google.com/./articles/CBMiiwFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvZ2FzdHJvZW50ZXJvbG9neS8yMDIyMTEwOC9lZnJ1eGlmZXJtaW4taW5kdWNlcy1uYXNoLXJlc29sdXRpb24taW1wcm92ZXMtZmlicm9zaXMtYnktYXQtbGVhc3QtMS1zdGFnZS12cy1wbGFjZWJv0gEA?hl=en-US&gl=US&ceid=US%3Aen
10 Best Small-Cap Stocks To Buy Now,nan,https://news.google.com/./articles/CBMiRmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy8xMC1iZXN0LXNtYWxsLWNhcC1zdG9ja3MtMjI1MzA1NTY0Lmh0bWzSAU5odHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy8xMC1iZXN0LXNtYWxsLWNhcC1zdG9ja3MtMjI1MzA1NTY0Lmh0bWw?hl=en-US&gl=US&ceid=US%3Aen
"Acrivon stock jumps 33% following $94M IPO, shares price below ...",nan,https://news.google.com/./articles/CBMibWh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9uZXdzLzM5MDgxMzQtYWNyaXZvbi1zdG9jay1yaXNlcy1tb2Rlc3RseS1mb2xsb3dpbmctOTRtLWlwby1zaGFyZXMtcHJpY2UtYmVsb3ctcmFuZ2XSAQA?hl=en-US&gl=US&ceid=US%3Aen
ENDRA Life Sciences Inc. (NDRA) Q3 2022 Earnings Call Transcript,nan,https://news.google.com/./articles/CBMiZmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1NTc2OTctZW5kcmEtbGlmZS1zY2llbmNlcy1pbmMtbmRyYS1xMy0yMDIyLWVhcm5pbmdzLWNhbGwtdHJhbnNjcmlwdNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Scholz secures agreement allowing expats in China to use ...,nan,https://news.google.com/./articles/CBMibmh0dHBzOi8vd3d3LnBoYXJtYWxpdmUuY29tL3NjaG9sei1zZWN1cmVzLWFncmVlbWVudC1hbGxvd2luZy1leHBhdHMtaW4tY2hpbmEtdG8tdXNlLWJpb250ZWNoLWNvdmlkLTE5LXZhY2NpbmUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Akero Therapeutics Completes Enrollment of Phase 2b SYMMETRY ...,nan,https://news.google.com/./articles/CBMisQFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMi8xMi8yMS8yNTc4MjE4LzAvZW4vQWtlcm8tVGhlcmFwZXV0aWNzLUNvbXBsZXRlcy1FbnJvbGxtZW50LW9mLVBoYXNlLTJiLVNZTU1FVFJZLVN0dWR5LWFuZC1Bbm5vdW5jZXMtRXhwZWN0ZWQtMjAyMy1NaWxlc3RvbmVzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
Efruxifermin Granted FDA Breakthrough Therapy Designation for ...,nan,https://news.google.com/./articles/CBMijQFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAyMi8xMi8wOC8yNTcwMDgxLzAvZW4vRWZydXhpZmVybWluLUdyYW50ZWQtRkRBLUJyZWFrdGhyb3VnaC1UaGVyYXB5LURlc2lnbmF0aW9uLWZvci1OQVNILmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
Akero Therapeutics Reaches Analyst Target Price,nan,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvYWtlcm8tdGhlcmFwZXV0aWNzLXJlYWNoZXMtYW5hbHlzdC10YXJnZXQtcHJpY2XSAQA?hl=en-US&gl=US&ceid=US%3Aen
Propulsion of Nonalcoholic Steatohepatitis Pipeline as Novel and Extensive 150+ Therapies Likely to Enter in the Treatment Domain | DelveInsight,nan,https://news.google.com/./articles/CBMiZGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9wcm9wdWxzaW9uLW5vbmFsY29ob2xpYy1zdGVhdG9oZXBhdGl0aXMtcGlwZWxpbmUtbm92ZWwtMTUzMDAwMDczLmh0bWzSAWxodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9wcm9wdWxzaW9uLW5vbmFsY29ob2xpYy1zdGVhdG9oZXBhdGl0aXMtcGlwZWxpbmUtbm92ZWwtMTUzMDAwMDczLmh0bWw?hl=en-US&gl=US&ceid=US%3Aen
89Bio Stock: Let's Not Give Up Already (NASDAQ:ETNB),nan,https://news.google.com/./articles/CBMiR2h0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1NjU5MjktODliaW8tbGV0cy1ub3QtZ2l2ZS11cC1hbHJlYWR50gEA?hl=en-US&gl=US&ceid=US%3Aen
"Madrigal (MDGL), Viking Therapeutics (VKTX) Stocks Surge on ...",nan,https://news.google.com/./articles/CBMicWh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIyLTEyLTE5L21hZHJpZ2FsLXN0b2NrLXRyaXBsZXMtYXMtbGl2ZXItZGlzZWFzZS1kcnVnLXN1Y2NlZWRzLWluLXRyaWFs0gEA?hl=en-US&gl=US&ceid=US%3Aen
5 Best Performing Biotech Stocks in 2022,nan,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3Lmluc2lkZXJtb25rZXkuY29tL2Jsb2cvNS1iZXN0LXBlcmZvcm1pbmctYmlvdGVjaC1zdG9ja3MtaW4tMjAyMi0xMTAzNjQ3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
5 Best Performing NASDAQ Stocks in 2022,nan,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3Lmluc2lkZXJtb25rZXkuY29tL2Jsb2cvNS1iZXN0LXBlcmZvcm1pbmctbmFzZGFxLXN0b2Nrcy1pbi0yMDIyLTExMDMyMDYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"US Bancorp DE Increases Stake in Akero Therapeutics, Inc ...",nan,https://news.google.com/./articles/CBMiTGh0dHBzOi8vd3d3Lm1hcmtldGJlYXQuY29tL2luc3RhbnQtYWxlcnRzL25hc2RhcS1ha3JvLXNlYy1maWxpbmctMjAyMy0wMS0yNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Apogee Therapeutics Appoints Jane Pritchett Henderson as Chief ...,nan,https://news.google.com/./articles/CBMiWWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hcG9nZWUtdGhlcmFwZXV0aWNzLWFwcG9pbnRzLWphbmUtcHJpdGNoZXR0LTEyMDAwMDY5My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen
Akero Therapeutics Appoints Patrick Lamy as Senior Vice President ...,nan,https://news.google.com/./articles/CBMinQFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMy8wMS8xMC8yNTg2MTEwLzAvZW4vQWtlcm8tVGhlcmFwZXV0aWNzLUFwcG9pbnRzLVBhdHJpY2stTGFteS1hcy1TZW5pb3ItVmljZS1QcmVzaWRlbnQtQ29tbWVyY2lhbC1TdHJhdGVneS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023",nan,https://news.google.com/./articles/CBMieWh0dHBzOi8vbWFya2V0cy5idXNpbmVzc2luc2lkZXIuY29tL25ld3Mvc3RvY2tzL2JlbnppbmdhLXMtdG9wLXJhdGluZ3MtdXBncmFkZXMtZG93bmdyYWRlcy1mb3ItamFudWFyeS0yNy0yMDIzLTEwMzIwNDY5NzjSAQA?hl=en-US&gl=US&ceid=US%3Aen
Bay Area's biggest life science stock winners and losers in 2022 ...,nan,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5qb3NlL25ld3MvMjAyMy8wMS8xMS9iaWctYmF5LWFyZWEtbGlmZS1zY2llbmNlLXN0b2NrLXdpbm5lcnMtbG9zZXJzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
Tracking Baker Brothers Portfolio â€“ Q3 2022 Update,nan,https://news.google.com/./articles/CBMiUGh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1NjgyMjItYmFrZXItYnJvdGhlcnMtcG9ydGZvbGlvLXEzLTIwMjItdXBkYXRl0gEA?hl=en-US&gl=US&ceid=US%3Aen
Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish,nan,https://news.google.com/./articles/CBMiaGh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1Njg3MTMtYmlvdGVjaC1ib25hbnphLTIwMjMtYmlvdGVjaC1vdXRsb29rLWFzLXRoZS1mZWQtcmVtYWlucy1oYXdraXNo0gEA?hl=en-US&gl=US&ceid=US%3Aen
Inventiva Revises Phase III NASH Plans For Broader Indication,nan,https://news.google.com/./articles/CBMic2h0dHBzOi8vc2NyaXAucGhhcm1haW50ZWxsaWdlbmNlLmluZm9ybWEuY29tL1NDMTQ3NjE0L0ludmVudGl2YS1SZXZpc2VzLVBoYXNlLUlJSS1OQVNILVBsYW5zLUZvci1Ccm9hZGVyLUluZGljYXRpb27SAQA?hl=en-US&gl=US&ceid=US%3Aen
DelveInsight Evaluates a Robust Nonalcoholic Fatty Liver Disease ...,nan,https://news.google.com/./articles/CBMi0AFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAyMy8wMS8wMi8yNTgxNzUyLzAvZW4vRGVsdmVJbnNpZ2h0LUV2YWx1YXRlcy1hLVJvYnVzdC1Ob25hbGNvaG9saWMtRmF0dHktTGl2ZXItRGlzZWFzZS1QaXBlbGluZS1hcy0xMTAtSW5mbHVlbnRpYWwtUGhhcm1hLVBsYXllcnMtdG8tU2V0LUZvb3QtaW4tdGhlLURvbWFpbi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen
Bank of America upgrades FibroGen to Buy on favorable risk-reward ...,nan,https://news.google.com/./articles/CBMidmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9uZXdzLzM5MjI0NDEtYmFuay1vZi1hbWVyaWNhLXVwZ3JhZGVzLWZpYnJvZ2VuLXRvLWJ1eS1vbi1mYXZvcmFibGUtcmlzay1yZXdhcmQtc3RvY2stZ2FpbnMtMTbSAQA?hl=en-US&gl=US&ceid=US%3Aen
"Akero Therapeutics Inc. [AKRO] stock for 252,651 USD was sold by Yale Catriona",nan,https://news.google.com/./articles/CBMibGh0dHBzOi8va25veGRhaWx5LmNvbS8yMDIzLzAxLzE5L2FrZXJvLXRoZXJhcGV1dGljcy1pbmMtYWtyby1zdG9jay1mb3ItMjUyNjUxLXVzZC13YXMtc29sZC1ieS15YWxlLWNhdHJpb25hL9IBcGh0dHBzOi8va25veGRhaWx5LmNvbS8yMDIzLzAxLzE5L2FrZXJvLXRoZXJhcGV1dGljcy1pbmMtYWtyby1zdG9jay1mb3ItMjUyNjUxLXVzZC13YXMtc29sZC1ieS15YWxlLWNhdHJpb25hL2FtcC8?hl=en-US&gl=US&ceid=US%3Aen
"Akero Therapeutics, Inc. (NASDAQ:AKRO) Sees Large Drop in Short ...",2023-02-16 20:00:45.630985,https://news.google.com/./articles/CBMiVWh0dHBzOi8vd3d3Lm1hcmtldGJlYXQuY29tL2luc3RhbnQtYWxlcnRzL25hc2RhcS1ha3JvLW9wdGlvbnMtZGF0YS1yZXBvcnQtMjAyMy0wMi0xNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Insiders who sold Akero Therapeutics, Inc.'s (NASDAQ:AKRO) earlier this year didn't have to weather this week's 5.4% slide",2023-02-13 20:00:45.631125,https://news.google.com/./articles/CBMimAFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1ha3JvL2FrZXJvLXRoZXJhcGV1dGljcy9uZXdzL2luc2lkZXJzLXdoby1zb2xkLWFrZXJvLXRoZXJhcGV1dGljcy1pbmNzLW5hc2RhcWFrcm8tZWFybGllctIBnAFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1ha3JvL2FrZXJvLXRoZXJhcGV1dGljcy9uZXdzL2luc2lkZXJzLXdoby1zb2xkLWFrZXJvLXRoZXJhcGV1dGljcy1pbmNzLW5hc2RhcWFrcm8tZWFybGllci9hbXA?hl=en-US&gl=US&ceid=US%3Aen
Alkeon Capital Management Updates Holdings in Akero ...,2023-02-13 20:00:45.631309,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvYWxrZW9uLWNhcGl0YWwtbWFuYWdlbWVudC11cGRhdGVzLWhvbGRpbmdzLWluLWFrZXJvLXRoZXJhcGV1dGljcy1ha3Jv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Akero Therapeutics, Inc. is purchased by Connor Clark & Lunn ...",2023-02-19 20:00:45.631500,https://news.google.com/./articles/CBMiSGh0dHBzOi8vYmVzdHN0b2Nrcy5jb20vYWtlcm8tdGhlcmFwZXV0aWNzLWluYy1pcy1wdXJjaGFzZWQtYnktY29ubm9yLWNsL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Akero Therapeutics: Attractive, Awaiting Additional Price Catalysts ...",2023-02-08 20:00:45.631676,https://news.google.com/./articles/CBMifmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1NzYzMDctYWtlcm8tdGhlcmFwZXV0aWNzLW5hc2gtZGlmZmVyZW50aWF0b3ItYXR0cmFjdGl2ZS1hd2FpdGluZy1hZGRpdGlvbmFsLXByaWNlLWNhdGFseXN0c9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Woodmont Investment Counsel LLC Cuts Stock Holdings in Akero ...,2023-02-03 20:00:45.631850,https://news.google.com/./articles/CBMiTGh0dHBzOi8vd3d3Lm1hcmtldGJlYXQuY29tL2luc3RhbnQtYWxlcnRzL25hc2RhcS1ha3JvLXNlYy1maWxpbmctMjAyMy0wMi0wMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Non Alcoholic Fatty Liver Pipeline Analysis Demonstrates Novel 110 ...,2023-02-21 07:00:45.631990,https://news.google.com/./articles/CBMivAFodHRwczovL3d3dy5kaWdpdGFsam91cm5hbC5jb20vcHIvbmV3cy9ub24tYWxjb2hvbGljLWZhdHR5LWxpdmVyLXBpcGVsaW5lLWFuYWx5c2lzLWRlbW9uc3RyYXRlcy1ub3ZlbC0xMTAtdGhlcmFwaWVzLWF0LXRoZS1ob3Jpem9uLWV4cGVjdGVkLXRvLXRyYW5zZm9ybS10aGUtdHJlYXRtZW50LXBhcmFkaWdtLWRlbHZlaW5zaWdodNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Penny Stocks & The Stock Market This Week Feb. 21-24,2023-02-21 03:00:45.632121,https://news.google.com/./articles/CBMiXmh0dHBzOi8vcGVubnlzdG9ja3MuY29tL2ZlYXR1cmVkLzIwMjMvMDIvMjAvcGVubnktc3RvY2tzLXRoZS1zdG9jay1tYXJrZXQtdGhpcy13ZWVrLWZlYi0yMS0yNC_SAV5odHRwczovL3Blbm55c3RvY2tzLmNvbS9mZWF0dXJlZC8yMDIzLzAyLzIwL3Blbm55LXN0b2Nrcy10aGUtc3RvY2stbWFya2V0LXRoaXMtd2Vlay1mZWItMjEtMjQv?hl=en-US&gl=US&ceid=US%3Aen
Non-Alcoholic Steatohepatitis Pipeline Analysis Demonstrates Novel 100+ Therapies at the Horizon Expected to T,2023-02-16 20:00:45.632261,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8yOTMzNTcyL25vbi1hbGNvaG9saWMtc3RlYXRvaGVwYXRpdGlzLXBpcGVsaW5lLWFuYWx5c2lz0gFSaHR0cHM6Ly93d3cub3BlbnByLmNvbS9hbXAvMjkzMzU3Mi9ub24tYWxjb2hvbGljLXN0ZWF0b2hlcGF0aXRpcy1waXBlbGluZS1hbmFseXNpcw?hl=en-US&gl=US&ceid=US%3Aen
